FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields

抗辐射性 成纤维细胞生长因子受体 癌症研究 替莫唑胺 癌症 医学 成纤维细胞生长因子受体1 克隆形成试验 成纤维细胞生长因子 肿瘤科 生物 受体 放射治疗 内科学 胶质瘤 细胞 遗传学
作者
Pauline Deshors,Ziad Kheil,Laetitia Ligat,Valérie Gouazé‐Andersson,Elizabeth Cohen‐Jonathan Moyal
出处
期刊:Cell death discovery [Springer Nature]
卷期号:11 (1)
标识
DOI:10.1038/s41420-025-02542-5
摘要

Abstract Glioblastomas (GBM) are aggressive tumors, which systematically relapse despite standard treatment associating surgery, chemotherapy and radiation therapy. More recently, GBM therapy now includes another therapeutic modality option, Tumor Treating Fields (TTFields) given in combination with Temozolomide (TMZ) following standard treatment. However even with the adjunction of TTFields, GBM remains a lethal disease due to treatment resistance. One of the causes of resistance is the presence of cancer stem cells (GSC) known to be chemo and radioresistant and responsible for tumor regrowth. Studying mechanisms of resistance of GSC to TTFields is thus a major issue to address. Fibroblast Growth Factor Receptors (FGFR) play a major role in numerous processes essential for cancer development, and dysregulation of FGFR signaling has been observed in many cancer types, including GBM. We have previously shown that tyrosine kinase receptor Fibroblast Growth Factor Receptor 1 (FGFR1) controls GBM aggressiveness and GSC radioresistance and that its inhibition leads to radiosensitization through increasing mitotic cell death and microenvironment modulation. Because one of the main mechanisms of action of TTFields is mitotic disturbance and because TTFields act synergistically in vitro with irradiation (IR), we hypothesize that targeting FGFR could sensitize GSC to TTFields. Here we show that, like IR, TTFields significantly decrease GSC growth. Treatment of GSC with pemigatinib (Pem), a FGFR1-3 inhibitor, alters FGFR signalling pathway. We demonstrate that Pem, sensitizes GSC to TTFields by synergistically decreasing their survival and clonogenic ability. Finally, the adjunction of Pem to treatment combining IR and TTFields could sensitize GSC by inducing, in some GSC, a further decrease in the repair of IR-induced DNA damages. Altogether, these results highlight the potential benefits of inhibiting FGFR with the concomitant application of TTFields in the first-line standard GBM treatment to improve patient prognosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HJJHJH发布了新的文献求助10
2秒前
Nole的应助被苦瓜采纳,获得10
3秒前
上官若男的应助被阔达的冰露采纳,获得10
3秒前
4秒前
桐桐的应助被Vater采纳,获得10
5秒前
可爱的函函的应助被HJJHJH采纳,获得10
6秒前
6秒前
dxw完成签到,获得积分10
6秒前
7秒前
77完成签到,获得积分10
9秒前
眼睛大的小熊猫完成签到,获得积分10
9秒前
清爽难破完成签到 ,获得积分10
11秒前
11秒前
NingCp完成签到,获得积分10
12秒前
12秒前
13秒前
13秒前
13秒前
传奇3的应助被quantu采纳,获得10
13秒前
踏实以松发布了新的文献求助10
13秒前
丘比特的应助被幽凡采纳,获得10
15秒前
林林完成签到 ,获得积分10
16秒前
坚强孤容发布了新的文献求助10
18秒前
18秒前
19秒前
迷你的寄云完成签到,获得积分10
21秒前
21秒前
22秒前
李麟发布了新的文献求助10
22秒前
思源的应助被邵蹦蹦采纳,获得10
23秒前
24秒前
xuejingling发布了新的文献求助10
24秒前
molihuakai的应助被长情豁采纳,获得10
24秒前
科研通AI6.2的应助被123采纳,获得10
24秒前
哈哈客发布了新的文献求助10
26秒前
在水一方的应助被百里采纳,获得10
26秒前
搜集达人的应助被坚强孤容采纳,获得10
27秒前
28秒前
28秒前
Hello的应助被徐XU采纳,获得10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186734
求助须知:如何正确求助?哪些是违规求助? 9575007
关于积分的说明 21839114
捐赠科研通 7784289
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611